Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.3399
-0.0301 (-8.14%)
At close: Nov 16, 2026, 4:00 PM EST
0.3530
+0.0131 (3.85%)
After-hours: Nov 16, 2026, 7:59 PM EST
Oncolytics Biotech Market Cap
Oncolytics Biotech has a market cap or net worth of $43.34 million as of November 16, 2026. It is the 30,826th most valuable company in the world and the 4,641st biggest in the United States. Its market cap has decreased by 63.15% in one year.
Market Cap
43.34M
Enterprise Value
39.67M
1-Year Change
-63.15%
Global Rank
Country Rank
#4,641 United States
Category
ChartMarket Cap Chart
Since September 30, 2002, Oncolytics Biotech's market cap has increased from $30.90M to $43.34M, an increase of 40.26%. That is a compound annual growth rate of 1.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 50.40M | -44.37% |
| Dec 31, 2025 | 90.60M | 28.69% |
| Dec 31, 2024 | 70.40M | -25.27% |
| Dec 29, 2023 | 94.20M | -0.95% |
| Dec 30, 2022 | 95.10M | 24.48% |
| Dec 31, 2021 | 76.40M | -24.21% |
| Dec 31, 2020 | 100.80M | -15.44% |
| Dec 31, 2019 | 119.20M | 341.48% |
| Dec 31, 2018 | 27.00M | -60.93% |
| Dec 29, 2017 | 69.10M | 178.63% |
| Dec 30, 2016 | 24.80M | -1.59% |
| Dec 31, 2015 | 25.20M | -43.88% |
| Dec 31, 2014 | 44.90M | -62.24% |
| Dec 31, 2013 | 118.90M | -57.43% |
| Dec 31, 2012 | 279.30M | 5.40% |
| Dec 30, 2011 | 265.00M | -35.74% |
| Dec 31, 2010 | 412.40M | 260.49% |
| Dec 31, 2009 | 114.40M | 129.72% |
| Dec 31, 2008 | 49.80M | -20.70% |
| Dec 31, 2007 | 62.80M | -17.04% |
| Dec 29, 2006 | 75.70M | -49.09% |
| Dec 30, 2005 | 148.70M | 19.06% |
| Dec 31, 2004 | 124.90M | 47.81% |
| Dec 31, 2003 | 84.50M | 194.43% |
| Dec 31, 2002 | 28.70M | -7.12% |
View and export this data all the way back to 2002. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 51.56M |
| RenovoRx | 50.18M |
| Mereo BioPharma Group | 49.10M |
| Nordicus Partners | 48.95M |
| MiNK Therapeutics | 47.66M |
| Werewolf Therapeutics | 47.64M |
| Rein Therapeutics | 47.63M |
| iBio, Inc. | 47.05M |